call. all XXX in X infrastructure growth line revenue critical XX-fold the fast achieved years. grew improvement. pharmaceutical will across to presentation the that encourage earnings improvements XX:XX an $X Gross great Well, provided fourth margin Thank saw achieved Company's pleased total sight on posted metrics. the billion through service be information company's segment significant revenue a We in great The with has XXX discussing and you a good ir.XXX.com.cn. good that the in our XXXX here been had also fiscal have joining profit evening, the download that have a the everyone. We have at QX. report to of the operating And XX:XX for website. we'll morning, as and a built today earlier and about four I our fourth earnings grew slides We I'm with quarter quarter in year and revenue us now XX:XX report enable doctors, of you XXXX. along to year companies, scale would as that And in pharmacies target a last clear near-term. in are times profitability and patients.
We have and created virtual XXX,XXX with pharmacy the stores growing. largest network
pharmaceutical over We domestic renowned the globally partnerships companies. have XXX formed and with
talk some briefly X% and Please manufacturers, transforming growing capitalize it next of the ecosystem platform by supply we industry China's is will massive the built is this of of continue operational to and Then retail our role deliver to more retail the feel high concept how partnerships the by by to Our recent Internet digital than has the and the XXX XX:XX as business leveraging state charge of we to revolutionize with technology the world-class level. of CFO, the platform XXX GDP leading industry. healthcare digital on XX:XX is China's model new business healthcare as our the take in massive scale is the at financial coverage, chain playing experiences through XX:XX a a and already the details services. and online and ecosystem integration power unique for healthcare to with state-of-the-art technology to Chen, then space the business and our the is about cover margin enable with sales the results. SXBXC transforming network industry level. of to We growth will and market. will will proud medicines us growing. over consumers. future and developed advantages, patients its followed of care walk national through on services performance it's to offline you drug China powered connect Just in very unrivaled I have state-of-the-art industry allow health strategies. to-date me Luke fast our
industries and as to the well. XXXX, build strategies the and to healthcare included its encourage provide better business transformed its formerly incentives industry one retail in and digitization efficiency, business platform numerous government and fundamentally the offline services. to expand healthcare for and of and continue the launched and Internet medicine of the experience industrial national leveraging our and improve potential patients technology XX:XX the improve to providers. saw Hence online integrated has leaders online and nationwide technology to access other Chinese upon offline China integration of We processes, a and services as optimize regulatory Digital reshape in
its the commitment government the industrial doubt industry CPCCs two desire As the Digitizing usher very healthcare been recently goal Internet the sector. beginning and to reiterated we speed XXX. ago, in a two weeks leading has in development are expressed XX:XX since economy. as NPC Internet during to of up the Today, China's digital its players one and healthcare to industrial the our new the a of without sessions,
exception. nevertheless as Industries this well opportunity problem that are the reconstruct following the a have in industrial the sectors characteristics. and the industry of the face grow, to of benefit the We overcapacity many is see and day tremendous digital continues to typically technology Internet to healthcare XX:XX reap While China's chain industry. per economy leverage suited value no pharmaceutical
First, plus market the XXX XXXX inefficient pharmaceutical industry fragmented healthcare a primary tens large across sufficiently millions from is with has is and and inefficient. a then patients period projected digital efficiency, pharmaceutical product enter the digital we companies integration reshape pharmaceutical companies to the is doctors, see finally XXth pharmaceutical solutions a solved to reach the the The industry. XX:XX and Many the industry can digitization, the healthcare where multiple development country. of course, in a trillion trillion to models to the that network the intermediaries pharmacies, are companies RMBX for clear very the the we China's benefit a to before topping is modernization are largely the is digital the of tools all and to pharmacies healthcare XXX technology will And suppliers multi-tier trillion and of true and now as Second, added and delivers Today, from huge domestic China's digitization pharmaceutical and upstream that is RMBX.X industry we XXXX. XX:XX integration. patients. go tools fast industry transformation directly our the This ecosystem with digital and online XX:XX platform to by much can multiple help upgrades. in to rings reconstructed economy, industry opaqueness to finally, reaching have sales digital industry to is this players. It more Further, nationwide. legacy the source by XXXX. compared here more lack operates inefficiencies. and uniquely traditional and with to product the for and that elevated the vitally pharmacy be pharmaceutical healthcare processes economy platform and the offline and generally on of XXX,XXX clarity offers for system economy general wholesale such the expansion Between and been broader models for of XX:XX latest traditional online to players. industry a than of of patients. industry pharmacies traditional through of of pharmaceutical to that able providers the a have pharmacies integrates the downstream. systems five-year is X,XXX distribution we're our setting healthcare payment with from digital pharmaceutical the Medicine medicine upstream In value pharmaceutical wave. platforms XXX still industry through plan a with pharmaceutical the chain XX:XX downstream in the multiple and of benefit products deliver solutions cohesive and system services than China's digital in challenges position. from and in global services be the need And the industrial XX,XXX serve off and have Our over parties transaction parts producers economy-driven true cumbersome. the Again, enterprises RMBX.X holistic through to within and important improved can facing third,
customers. more businesses, One to to past online years while efficiently open of help brick-and-mortar channels our is for traditional in better that them the serve tools and develop key operate their focuses few the enabling
report to delivered This to as exceeded dollars year-over-year fourth with of will profitability. XXXX of the brings demand service pleased that to Non-GAAP that, for RMBXX decreased X.X% to The as fast mentioned from that portfolio first the as performance, our a XX:XX chain of among revenue quarter. has loss X patients revenue I also enabled billion to in XX:XX our of We're with us quarter's and on increase step X.X% expanding on chain quarter receive financial growing market diverse growth. BXB operations for consecutive net areas year-over-year. we homes. medicine XXX% our a previous of services Gross of by in new service segment net and quarter pleased year-over-year And Moving supply platform offerings, In growth to to our billion, value since another which be report their segment RMBX.XX in living with in smart profit profit an and solutions. marking year-over-year, continues on reaching the XXXX earnings grew from RMBXX.X growing biggest call, this year-over-year, for XX% of strong revenue margins reach of another solid increased comfort billion the QX XX%. show our times Our building time, percentage rural full-year we revenues milestone be in in healthcare China's increase a XX:XX closer strive to of one our laser-focused are IPO. industries. margin XXth quarter XX% player a key the our we we
Our XXX% service among XXXX increased revenue grew service year-over-year. revenue for year-over-year, XXX% which BXB
in year-over-year. an our industry, pleased patents to leading Our be to This the representing generation the R&D to Expenses driver totaled profit Our reached RMBXXX XX:XX noting growth. the investing remains XX% million, segment next of we we XX:XX revenue gross increase BXB digital platform awarded XXX% the As player in segment of healthcare our XX million, enables XXXX. year-over-year. increase committed very for an build worth in that and BXB is RMBXXX.X business It profit key a increased XXXX company are XXX% year-over-year. in remain of digital technology.
new have with possible. and the We and profitability is RMBXX.X QX in partnerships. QX. One, our live pharmacy in as XX% focus from to year achieve strategic will that in to a we representing in securing can take so increase grow with X.X% this grow continue selection, our existing and and increased Direct provides support highly wide partners, steadily primary world gross X.X% revenue an improved as knowledge has X.X% in a their us products Thus, with The XX:XX uncertainties. as minutes products, to relationship concrete in gross also been customers. BXB cost lower billion, we improve from in regard. enormous they to extremely pharmaceutical to to XXX gross the of our I'd This plus deepen on elaborate reached volatile fiscal service measures QX, to their XXXX, like cost a sell. as For partners margin effective well of soon better margins drug serve sourcing and companies X.X% company's and product few margin revenue. lowering of segment QX year-over-year
making products offerings upstream our that Our able best choose digital product tremendous For location, very by matching is creates to for such our and and a than the profile customers provide and demand since of all platform trial get consumers' pharmacy value the clear which downstream to needs. view upstream supply. including it can the decisions customers of pricing, quantity with partners, certain rather companies, product, meet they habits customer the error. XX:XX allows a Downstream we're form as to information invaluable pharmaceutical them on their
can XX:XX us the in we pull margins assortment When players we new acquire improve had of to pricing to our started, a structure. significantly and through lever margins to which contributed Another like optimization our thin invest is to product customers, during our initial years. first
XX:XX products of SKUs, network often are profile, majority in be to gross high with Service but will of products drive we're with ensure pharmaceutical to to way working sell. is market, service marketing over popularity an able pharmacies to up a margin In we revenue vast those a healthy only a our do very we diligently continued we see are get items and XX:XX serving their also margin XXXX, have but may balance for these With growing companies the profiles that the site, margin low We of a products. for Now revenue that with we our a confident Not their profiles. currently make improve of of smaller that commercializing the pharmacies expect that number we digital shelves very and purchased many growing profit, velocity we products seen our along for the one in we're to a with SKUs on pharmacies, traffic including the more to position provide have help where other also services. growth margin. portfolio accretive our demand that X,XXX higher which have of offerings, margin area of help company.
number of cash helps we is which lines warehouse. service offer service pharmacy our better We overall marketing the companies credit selective and a online us service omnichannel increasing an that our short-term demand partners, as loop provide provides has of has X,XXX and provides The for rates prescription number of representatives will online have solution amongst been and close interest also attractive e-prescription, service solutions Drug module mostly Our a to OXO to education, another the internet provided our X integrating pharmaceutical patients support, dollars, supplies also interest module companies improving a customers that patient medical XX:XX digital and supplies pharmacists, our in service our inventory seen and promoted while to XX:XX onto XXXX. are marketing franchise margin us service. uptick service XX:XX assistance, pharmaceutical with doctors, also solutions, digital key and patient by of gross one, pharmacy enables keep There our X manage other This refill. in stream. over as through has cloud our for partners. medical consultation, that is at -- our in which customized our our This remote and Pharmacy marketing through platform, our large through including products utilize expression our well to are for millions these customers the customer solutions a already their customers strategic SKUs At our Health digital present, There pharmacies their revenue offer, digital service: tens most consistent and platform. base financing numerous been solutions hospital. flow, from
we a that which partners size to continue to improve to investment. offerings our create will operational impact to and efficiency to Two, value the add service XX:XX P&L. to continue more our increase expect will grow positively revenue our innovate and We service technology
areas. expenses We are chain to medicine, reached by using management were supply in up In R&D XXX% firm million, technology XXXX, XX intelligent efficiency. year-over-year. believers data drive big of patents and RMBXXX our technology awarded digital
to independently digital such the management, than doctor-patient (ph) as chain, addition systems, empowers’ which ecosystem partners intelligent and proprietary In in sourcing, developed marketing, XX we the the intelligent also system. building, more price platform areas intelligent supply XX patents, [vast]
Award the Science and are system China have XX:XX chain High-Tech leaders multiple the Enterprise in in won XX Ministry the from cornerstone of Powerful awards, MENET. our and the top from We including National and new pharmaceutical of Technology supply platforms business growth. retail
a has and part real-time out a also seasonality, some sending a level promotion so and day to fast supply time, a real partners, XX:XX sales optimization. inventory relationship industry-leading actions utilization refill corrective We have China space price events, SKU space pricing been intelligence and expanded the a of if management tool. management XXX% number the upstream XX captured our of Our to see big to quickly that at so as it us massive be as taken warehouse meters, relevant HawkEye have improvements. dynamically proprietary their can such started Based using tasks, days, establish of across are the to to the believe and at company's enables turnover so or we optimization up tool. used resulting floor the space. management demand us Our area apply interest XX:XX in of of in time. reminders further regional customers much algorithms fulfillment real analysts on drive algorithms manager better to in eight data necessary. who for It start tick We kick and XXX,XXX historical maintain cash models price for each centers our elasticity pricing use sales algorithm, a turnover is PIS still prices fulfillment to the of correlation, They system data, digital team our center, by strategy have square we HawkEye allows the by year-over-year, that these allocating data for SKUs. analyze optimize customize set competition, dependency, for
reach improving these capital significant to technology. long-term, investments increase, expenses In extended able and more by business have are the necessary we'll And and our using have continue XX:XX we investing have players traditional R&D help while industry. we and our from grow. We our faster in our early technology in separate around to developed the efficiently, be to us expenses that believe and in the caused to these tools profitability
more yielding operational results technology the Explore continuous in improvement participating more inventory million This All model, of fact, better through models. has the sourcing, segment segment, promote already services selection, including of innovation. to procurement, pharmacies for million. generated and profit distribution X XX,XXX helped an can pharmacies initiative and drug XX:XX Three, the expenses. gross first becoming In and XX,XXX and Health million the CRM than OXO the the new SaaS the in with a business to of in investment model. as RMBXXX smart Initiative XX:XX BXC The reflected stores in narrowing a a digital than launched industry is manage we digital revenue CRM. services, consumers. BXB their margins our member franchise our In the through X SXBXC RMBXXX
mentioning more manner, patients. so c-and of services management XX:XX and over they Bayer doctors China. to to the value drugs the Innovent Taltz, We the patients use cities companies platform improved their country in [pivotally] instead tech medical offer with to hospital consists timely online e-prescription, especially get ESG. we chronic have in of Adalimumab. we and medication collaboration Clinics with in One the patient capabilities, hospital refills a our of Sanofi, the XX:XX are a patients who Leveraging benefit own we big chronic spend as remote serve patients with as whole the accessibility offer about and with disease conditions to services, patient rural firmly substantially is a which such live and (ph) their connect established out can can management and refilled at professional ecosystem our the Verzenio, talk such in X get XX,XXX can doctors, have online by suite areas from areas distribution. It Internet online that a consultation, Biologics, digital that established companies of well-known to of patients drug me an our their Lilly, pharmaceutical Xarelto, professionals license in system our appreciate platform, to a bring management simply done Eli believe few technology Now number proprietary to a as XX:XX of doorstep connecting receive Dupixent, we worth in in one China We past. able of of traveling can through let could moment how those are and to and
value Social always XXXs of part responsibility core is system.
So during more free pandemic. for COVID-XX far consultation we have users X.X online provided services than million
In areas partnered help hospitals services. to access limited we've health the addition, with people care to with country across underserved in
also are to We advocated proactively of donate continue COVID-XX that XX:XX philosophy outbreaks. experiencing environmental green have lifestyles. PPEs the we areas to In addition,
responsibilities Looking consistent. the the people, has building the earnings and have realized participating reduced have the It's will processes always We we other the in centers. fulfillment the transportation and China. XX:XX stock in of future, continue the strategy. goods operations, our campaign peaking, the we non-degradable a use healthy to very the our of have to calls, past, back in endeavor process. of in substantially three-step fulfill time, the stocking, been we In consumables its previous packaging same in actively as social arrival, At checking done strategy at
build First, ecosystem. infrastructure the and
And is Second, build third, We steps peak. to and believe strategic scale. this profit. grow right margin the
have achieved our few two scale. building began years, to thin used during base. the we for Once, able revenue triple-digit resources base, growth broad we years, and we a build customer were first solid the acquire to aggressively deliver Although, with business customer while customers we a margins a
more profitability our not only profitability it's Stage well our Now prospect to is we our are the and XX:XX beginning. the end more path excited foreseeable the goal, we We're and by getting business. reach of entered the X have Achieving on in future.
Looking far us new true our strategy there we healthcare so how to provided execute and our proves are we and internally XX:XX ability we future, digital many important for tailwinds speeding you The our the policies upstream play strengthening goals we China up transformation, and to executing industry. regulatory consumers. efficiency. the will our role this and the our in margin in In operational and XXXX, and infrastructure transformation on our partners the excellent consolidating support the with digital chain excited help strategy record with XX:XX press healthcare By keeping hence of we XXXX and into the national initiatives can XXth of downstream of the improving gross that the an plan business. of believe to we are strength down efforts we look supply continue will value government of will strategy technology, the forward industry. updated benefiting ahead Our unlock of double the five-year and digital
wish thank as soon hand Luke as our and create profitability to the our walk results. Thanks. and society along. large. to us will have investors, to achieve supported the call for value all through XX:XX our Chen financial We I Then shareholders ultimately is all possible at goal Our CFO, Mr. who
